AIM Company Profile and Key Details

Q: Who are the executives of AIM?

Dr. Carol A. SmithChief Manufacturing Officer & Deputy Chief Scientific OfficerDr. Christopher McAleer Ph.D.Scientific OfficerDr. David R. Strayer M.D.Chief Scientific Officer & Medical DirectorAnn Marie E. CoverlyDirector of Admin. & HR and Deputy Investor Relations CoordinatorJodie PelzControllerDr. Ralph Christopher Cavalli Ph.D.Vice President of QC & ManufacturingMr. Thomas K. Equels Esq., J.D., M.S.Executive Vice Chairman, Chief Executive Officer & PresMr. Peter W. Rodino III, Esq., J.D.Chief Operating Officer, Executive Director of Gov.al Relations, Gen. Counsel & Sec.

AMEX : AIM

AIM ImmunoTech

$1.23

0.175+16.59%

At Close 4:00 PM

63.57

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

AIM ImmunoTech Inc. (AIM) stock surged +16.59%, trading at $1.23 on AMEX, up from the previous close of $1.06. The stock opened at $1.72, fluctuating between $1.16 and $1.88 in the recent session.

Stock Snapshot

1.055

Prev. Close

4.03M

Market Cap

1.16

Day Low

-0.07

P/E Ratio

-18.16

EPS (TTM)

-0.45

Cash Flow per Share

1.72

Open

3.28M

Number of Shares

1.8799

Day High

95.49%

Free Float in %

0.21

Book Value

67.79M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 05, 2026	1.72	1.88	1.16	1.23	68.13M
Feb 04, 2026	1.17	1.17	1.03	1.06	75.87K
Feb 03, 2026	1.23	1.23	1.13	1.15	79.36K
Feb 02, 2026	1.15	1.23	1.10	1.21	97.42K
Jan 30, 2026	1.16	1.21	1.15	1.15	71.54K
Jan 29, 2026	1.22	1.22	1.15	1.15	83.75K
Jan 28, 2026	1.21	1.23	1.19	1.22	141.92K
Jan 27, 2026	1.24	1.24	1.18	1.21	39.86K
Jan 26, 2026	1.21	1.22	1.18	1.21	103.73K
Jan 23, 2026	1.30	1.32	1.18	1.20	137.85K
Jan 22, 2026	1.18	1.28	1.15	1.26	111.16K
Jan 21, 2026	1.20	1.20	1.13	1.17	95.8K
Jan 20, 2026	1.30	1.30	1.15	1.18	208.98K
Jan 16, 2026	1.32	1.39	1.31	1.34	132.46K
Jan 15, 2026	1.32	1.34	1.26	1.34	61.36K
Jan 14, 2026	1.30	1.31	1.22	1.31	67.45K
Jan 13, 2026	1.25	1.29	1.20	1.27	74.43K
Jan 12, 2026	1.32	1.32	1.20	1.25	71.18K
Jan 09, 2026	1.40	1.40	1.26	1.29	153.97K
Jan 08, 2026	1.28	1.34	1.26	1.34	33.06K

Contact Details

Ocala, FL 34473

United States

https://aimimmuno.com 352 448 7797

About Company

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. Its flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. The company is also developing Ampligen for potential treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

Stock Peers

TBXU

-0.2104-0.60%

Direxion Shares ETF Trust$35.11 PTN

0.13+0.82%

Palatin Technologies, Inc.$16.05 AGE

-1.5-11.90%

AgeX Therapeutics, Inc.$11.10 CYBN

0.1+1.22%

Cybin Inc.$8.28 ARMP

-0.02-0.25%

Armata Pharmaceuticals, Inc.$8.08 NSRX

-0.25-4.31%

Nasus Pharma Ltd.$5.55 CVM

-0.11-2.20%

CEL-SCI Corporation$4.90 PHGE

-0.73-13.80%

BiomX Inc.$4.56 CANF

0.21+5.20%

Can-Fite BioPharma Ltd.$4.25 PLX

0.01+0.34%

Protalix BioTherapeutics, Inc.$2.91

Frequently Asked Questions

What is the current AIM ImmunoTech Inc. (AIM) stock price?

AIM ImmunoTech Inc. (AMEX: AIM) stock price is $1.23 in the last trading session. During the trading session, AIM stock reached the peak price of $1.88 while $1.16 was the lowest point it dropped to. The percentage change in AIM stock occurred in the recent session was 16.59% while the dollar amount for the price change in AIM stock was $0.18.

AIM's industry and sector of operation?

The AMEX listed AIM is part of Biotechnology industry that operates in the broader Healthcare sector. AIM ImmunoTech Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of AIM?

Dr. Carol A. Smith
Chief Manufacturing Officer & Deputy Chief Scientific Officer
Dr. Christopher McAleer Ph.D.
Scientific Officer
Dr. David R. Strayer M.D.
Chief Scientific Officer & Medical Director
Ann Marie E. Coverly
Director of Admin. & HR and Deputy Investor Relations Coordinator
Jodie Pelz
Controller
Dr. Ralph Christopher Cavalli Ph.D.
Vice President of QC & Manufacturing
Mr. Thomas K. Equels Esq., J.D., M.S.
Executive Vice Chairman, Chief Executive Officer & Pres
Mr. Peter W. Rodino III, Esq., J.D.
Chief Operating Officer, Executive Director of Gov.al Relations, Gen. Counsel & Sec.

How AIM did perform over past 52-week?

AIM's closing price is 19.42% higher than its 52-week low of $1.03 where as its distance from 52-week high of $36.00 is -96.58%.

How many employees does AIM have?

Number of AIM employees currently stands at 21.

Link for AIM official website?

Official Website of AIM is: https://aimimmuno.com

How do I contact AIM?

AIM could be contacted at phone 352 448 7797 and can also be accessed through its website. AIM operates from 2117 SW Highway 484, Ocala, FL 34473, United States.

How many shares of AIM are traded daily?

AIM stock volume for the day was 67.79M shares. The average number of AIM shares traded daily for last 3 months was 108.26K.

What is the market cap of AIM currently?

The market value of AIM currently stands at $4.03M with its latest stock price at $1.23 and 3.28M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	21
Beta	1.21
Sales or Revenue	$202.00K
5Y Sales Change%	-0.989%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	21
Beta	1.21
Sales or Revenue	$202.00K
5Y Sales Change%	-0.989%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

AIM Company Profile and Key Details

AIM ImmunoTech

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Shareholding & Insider Activity

Technical Performance

Company Overview

Dividend & Fair Value

Valuation Metrics

Price Forecast & Outlook

Key Takeaways